Financings In Brief
This article was originally published in The Gray Sheet
Executive Summary
Cancer Genetics plans initial public offering. Mitralign raises $35 million for valve repair device. More financings.
You may also be interested in...
News In Brief
Maquet acquires LAAx. OrbusNeich says it called the cops on Boston Scientific. More news
New Products In Brief
J&J/DePuy’s Trumatch
New Products In Brief
Sonitus’ SoundBite gains second FDA OK